The THRIVE score strongly predicts outcomes in patients treated with the Solitaire device in the SWIFT and STAR trials

ConclusionsThe THRIVE score strongly predicts clinical outcome and mortality in patients treated with the Solitaire device in the SWIFT and STAR trials. The lack of interaction between THRIVE and procedure‐specific elements such as vessel recanalization or device choice makes the THRIVE score a reasonable candidate for use as a patient selection criterion in stroke clinical trials.

Source: International Journal of Stroke - May 22, 2014 Category: Neurology Authors: Alexander C. Flint, Sean P. Cullen, Vivek A. Rao, Bonnie S. Faigeles, Vitor M. Pereira, Elad I. Levy, Tudor G. Jovin, David S. Liebeskind, Raul G. Nogueira, Reza Jahan, Jeffrey L. Saver, Tags: Research Source Type: research